---
figid: PMC5474223__nihms828650f8
figtitle: Histone Deacetylase Inhibitors Interrupt HSP90•RASGRP1 and HSP90•CRAF Interactions
  to Upregulate BIM and Circumvent Drug Resistance in Lymphoma Cells
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Diaporthe sclerotioides
- Bikinia letestui
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5474223
filename: nihms828650f8.jpg
figlink: /pmc/articles/PMC5474223/figure/F8/
number: F8
caption: Under normal circumstances, RASGRP1 and CRAF are bound to the HSP90 chaperone
  complex, which stabilizes them and facilitates signaling through the MEK/ERK pathway
  to induce phosphorylation-dependent BIM degradation. Treatment with romidepsin shifts
  the equilibrium in favor of HSP90 acetylation, causing release and degradation of
  RASGRP1 and CRAF, inhibition of MEK/ERK signaling, elevation of BIM and apoptosis.
  Interventions performed in this paper to dissect the pathway (and the corresponding
  figures) are indicated.
papertitle: Histone Deacetylase Inhibitors Interrupt HSP90•RASGRP1 and HSP90•CRAF
  Interactions to Upregulate BIM and Circumvent Drug Resistance in Lymphoma Cells.
reftext: Husheng Ding, et al. Leukemia. 2017 Jul;31(7):1593-1602.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8948696
figid_alias: PMC5474223__F8
figtype: Figure
redirect_from: /figures/PMC5474223__F8
ndex: 4295a4bd-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5474223__nihms828650f8.html
  '@type': Dataset
  description: Under normal circumstances, RASGRP1 and CRAF are bound to the HSP90
    chaperone complex, which stabilizes them and facilitates signaling through the
    MEK/ERK pathway to induce phosphorylation-dependent BIM degradation. Treatment
    with romidepsin shifts the equilibrium in favor of HSP90 acetylation, causing
    release and degradation of RASGRP1 and CRAF, inhibition of MEK/ERK signaling,
    elevation of BIM and apoptosis. Interventions performed in this paper to dissect
    the pathway (and the corresponding figures) are indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Rasgrp1
  - Raf1
  - ras
  - Hras
  - Kras
  - Rem1
  - Hsp90ab1
  - Hsp90aa1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Gopc
  - Map2k1
  - Map2k2
  - Mapk3
  - Bcl2l11
  - Bcl2
  - RASGRP1
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - TMPRSS11D
  - MTG1
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - DEPP1
  - GOPC
  - MAP2K1
  - MAP2K2
  - MAPK3
  - BCL2L11
  - BCL2
  - Ras64B
  - Ras85D
  - hat
  - Elp3
  - CG1894
  - chm
  - Hsp83
  - Gp93
  - fig
  - Dsor1
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Bm
  - Debcl
  - RpS4
  - Cancer
---
